###
中国临床研究:2025,38(6):919-924
本文二维码信息
码上扫一扫!
转化治疗序贯外科根治性手术切除巨块型肝癌病理完全缓解:1例多学科协作讨论
(昆明医科大学附属曲靖医院 曲靖市第一人民医院肝胆胰外科, 云南 曲靖 655000)
Pathological complete response of massive hepatocellular carcinoma treated by conversion therapy followed by radical surgical resection:a case discussion of multidisciplinary team
(Hepatobiliary and Pancreatic Surgery Department,Qujing No.1 Hospital,Affiliated Qujing Hospital of Kunming Medical University,Qujing,Yunnan 655000,China)
摘要
本文已被:浏览 403次   下载 19
投稿时间:2024-06-28   网络发布日期:2025-06-20
中文摘要: 目的 探讨多学科协作团队(MDT)模式在中晚期肝癌经靶向治疗+免疫治疗(靶免治疗)的转化治疗后序贯手术切除中的价值。方法 回顾性分析2021年5月曲靖市第一人民医院肝胆胰外科收治的1例初始不可切除的右肝巨块型肝癌,经MDT讨论后,制定个体化治疗方案并成功实施手术切除。结果 第一次MDT讨论:因肿瘤直径约12 cm,肝右及肝中静脉受侵,肿瘤不可一期根治性切除,予制定靶向、免疫、抗病毒、保肝治疗,经过9次靶免联合治疗,肿瘤直径由12.0 cm缩小至6.0 cm,肝右及肝中静脉的癌栓完全消失,转化效果显著;第二次MDT讨论:靶免联合的转化治疗成功降期,认为可安全实行根治性手术切除,积极术前准备,于2022年2月在全麻下行解剖型中肝切除术(S5、S8)+胆囊切除术,术后病理检查示(肝中叶)治疗后无存活癌细胞,肿瘤退缩分级0(完全反应),脉管内未见癌栓,肿瘤未累及被膜,未累及手术切缘,达到病理完全缓解;第三次MDT讨论:术后未见肿瘤细胞,达病理完全缓解,术后继续规律辅助靶免治疗1年,截至目前24个月,未见肿瘤复发转移情况,患者一般情况良好。结论 MDT对于中晚期肝癌的诊治提供了重要的临床价值,在为此类患者制定合理的个体化治疗方案、转化治疗后序贯根治性手术、术后根据病理反应程度选择合适的辅助治疗模式、延长患者生存时间中具有重要的临床意义。
Abstract:Objective To explore the value of a multidisciplinary team(MDT)approach in sequential surgical resection of intermediate and advanced hepatocellular carcinoma(HCC)after conversion therapy of targeted therapy combined with immunotherapy. Methods A retrospective analysis was conducted on a case of initially unresectable massive HCC of right liver treated in the Hepatobiliary and Pancreatic Surgery Department of Qujing No.1 Hospital in May 2021. After MDT discussion,an individualized treatment plan was formulated and successfully implemented,leading to surgical resection. Results (1)First MDT discussion:due to a tumor diameter of approximately 12 cm and invasion of the right and middle hepatic veins,the tumor was deemed unresectable in one stage. A treatment plan involving targeted therapy,immunotherapy,antiviral therapy,and liver protection was initiated. After 9 cycles of combined targeted and immunotherapy,the tumor diameter shrank from 12.0 cm to 6.0 cm,and the tumor thrombus in the right and middle hepatic veins completely disappeared,demonstrating significant conversion efficacy.(2)Second MDT discussion:the combined targeted and immunotherapy successfully down -staged the tumor,making radical surgical resection feasible.After thorough preoperative preparation,an anatomical middle hepatectomy (S5,S8) and cholecystectomy were performed under general anesthesia in February 2022. Postoperative pathological examination showed no viable cancer cells in the resected liver tissue,with a tumor regression grade of 0(complete response). No tumor thrombus was found in the vessels,and the tumor did not involve the capsule or surgical margins,achieving pathological complete remission.(3) Third MDT discussion:postoperative examination revealed no tumor cells,confirming pathological complete remission. The regular adjuvant targeted and immunotherapy was continued for one year. As of 24 months post -surgery,there has been no tumor recurrence or metastasis,and the patient has remained in good general condition. Conclusion MDT provides significant clinical value in the diagnosis and treatment of intermediate and advanced HCC. It is of great clinical significance in formulating reasonable individualized treatment plans for such patients,sequential radical surgery after conversion treatment,selecting appropriate adjuvant treatment models based on the degree of pathological reactions after surgery,and prolonging patient survival.
文章编号:     中图分类号:R735.7    文献标志码:B
基金项目:云南省科技厅基础研究计划昆医联合专项重点项目(202301AY070001?019);云南省科技厅基础研究计划昆医联合专项面上项目(202401AY070001?260);兴滇英才支持计划项目
附件
引用文本:
黎昭君, 方兴保, 李月宏, 刘培万, 张宏, 彭雄兵, 高泽娟.转化治疗序贯外科根治性手术切除巨块型肝癌病理完全缓解:1例多学科协作讨论[J].中国临床研究,2025,38(6):919-924.

用微信扫一扫

用微信扫一扫